89 related articles for article (PubMed ID: 1124712)
1. Unusual toxicities from cancer and immunosuppressive therapy.
Kahn SB
Am Fam Physician; 1975 Feb; 11(2):178-9. PubMed ID: 1124712
[No Abstract] [Full Text] [Related]
2. The pharmacology of immunosuppressive agents.
Mitchell MS; Bertino JR
Conn Med; 1970 Dec; 34(12):843-50. PubMed ID: 4923392
[No Abstract] [Full Text] [Related]
3. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
Schmähl D; Osswald H
Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
[No Abstract] [Full Text] [Related]
4. [Comparative study of the side effects of embikhin, sarcolysin and asalin].
Sof'ina ZP
Farmakol Toksikol; 1969; 32(3):312-6. PubMed ID: 5810949
[No Abstract] [Full Text] [Related]
5. Some antineoplastic and immunosuppressive agents.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():1-411. PubMed ID: 6944253
[No Abstract] [Full Text] [Related]
6. [Teratogenic, mutagenic and oncogenic lesions caused by immunosuppressive agents].
Rapp W
Verh Dtsch Ges Inn Med; 1972; 78():761-4. PubMed ID: 4665748
[No Abstract] [Full Text] [Related]
7. On the neurotoxic effects induced by alkylating agents.
Donelli MG; Rosso R; Garattini S
J Pharm Pharmacol; 1966 Nov; 18(11):760-2. PubMed ID: 4382059
[No Abstract] [Full Text] [Related]
8. [Side-effects of cytostatic and immunosuppressive therapy].
Hartwich G
Fortschr Med; 1973 Mar; 91(9):357-62. PubMed ID: 4633019
[No Abstract] [Full Text] [Related]
9. [Mutagenic activity of antineoplastic agents under conditions of normal and artificial modification].
Semenov VV
Genetika; 1990 Nov; 26(11):2020-7. PubMed ID: 2127408
[TBL] [Abstract][Full Text] [Related]
10. Chemical mutagens in the human environment.
Epstein SS; Shafner H
Nature; 1968 Jul; 219(5152):385-7. PubMed ID: 5662155
[No Abstract] [Full Text] [Related]
11. [Indications for immunosuppressive treatment in kidney diseases of children].
Wojnarowski M; Wyszyńska T
Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
[No Abstract] [Full Text] [Related]
12. [Experimental study of the antineoplastic effect of the antibiotic polymycin].
Terent'eva TG; Fomina IP; Navashin SM
Antibiotiki; 1970 May; 15(5):442-7. PubMed ID: 4988019
[No Abstract] [Full Text] [Related]
13. Chemical carcinogenicity and the antineoplastic agents.
Taylor AT; Wade AE
Am J Hosp Pharm; 1984 Sep; 41(9):1844-8. PubMed ID: 6496522
[TBL] [Abstract][Full Text] [Related]
14. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies.
Abe T; Tsuda S; Maekawa T; Taniwaki M; Sonoda Y; Ide T; Misawa S; Takino T; Inoue K
Cancer Treat Rep; 1985 May; 69(5):505-14. PubMed ID: 4005873
[TBL] [Abstract][Full Text] [Related]
15. [Effect of toxic doses of antineoplastic agents on cellular composition of porous connective tissue of mice].
Rozenberg IB
Farmakol Toksikol; 1970; 33(2):212-6. PubMed ID: 5425631
[No Abstract] [Full Text] [Related]
16. Residual marrow injury following cytotoxic drugs.
Trainor KJ; Seshadri RS; Morley AA
Leuk Res; 1979; 3(4):205-10. PubMed ID: 533991
[No Abstract] [Full Text] [Related]
17. The effect of cytostatic drugs on the synthesis of DNA in adenocarcinomas of the stomach. An in vitro study.
Håkansson L; Dahn I; Huldt B
Acta Chir Scand; 1975; 141(5):409-12. PubMed ID: 1179930
[TBL] [Abstract][Full Text] [Related]
18. Single cell analysis of DNA modifications induced by chemical carcinogens and cytostatic drugs.
Den Engelse L; Bax J; Terheggen PM; Van Schooten FJ; Van Benthem J; Wild CP; Scherer E
Ann Ist Super Sanita; 1989; 25(1):11-9. PubMed ID: 2751189
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of a protein complex from Viscum album on fibroblasts and HeLa cells.
Klamerth O; Vester F; Kellner G
Hoppe Seylers Z Physiol Chem; 1968 Jun; 349(6):863-4. PubMed ID: 5722830
[No Abstract] [Full Text] [Related]
20. Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
Palumbo A; Triolo S; Baldini L; Callea V; Capaldi A; De Stefano V; Grasso M; Liberati M; Lotesoriere C; Marcenò R; Marmont F; Musto P; Petrucci MT; Spriano M; Pileri A; Boccadoro M
Haematologica; 2000 May; 85(5):508-13. PubMed ID: 10800168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
